cyclopentolate has been researched along with Autoimmune Diabetes in 1 studies
Cyclopentolate: A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia.
cyclopentolate : A carboxylic ester resulting from the formal condensation of (1-hydroxycyclopentyl)(phenyl)acetic acid with N,N-dimethylethanolamine. A tertiary amine antimuscarinic with actions similar to atropine, it is used as its hydrochloride salt to produce mydriasis (excessive dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle of the eye) for opthalmic diagnostic procedures. It acts more quickly than atropine and has a shorter duration of action.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johansen, J | 1 |
| Sjølie, AK | 1 |
| Eshøj, O | 1 |
1 other study available for cyclopentolate and Autoimmune Diabetes
| Article | Year |
|---|---|
Refraction and retinopathy in diabetic children below 16 years of age.
Topics: Adolescent; Child; Cross-Sectional Studies; Cyclopentolate; Denmark; Diabetes Mellitus, Type 1; Diab | 1994 |